Anatomical Record-Advances in Integrative Anatomy and Evolutionary Biology, an esteemed journal published by WILEY, serves as a pivotal platform for scholars in the fields of anatomy, biotechnology, ecology, evolutionary biology, and histology. With an ISSN of 1932-8486 and an E-ISSN of 1932-8494, this journal has demonstrated its academic rigor by maintaining a Q2 ranking across multiple relevant categories, including Anatomy and Biotechnology, and consistently achieving a high Scopus ranking in its respective fields. Its scope, covering integrative approaches to anatomical research and evolutionary studies, fosters interdisciplinary collaboration and innovation. Researchers and practitioners can access the journal through various open-access options, ensuring that groundbreaking findings are disseminated widely. As a vital resource for advancing knowledge and exploring emerging trends, this journal greatly contributes to the understanding of biological systems and evolutionary processes, making it an essential read for those dedicated to pushing the boundaries of their respective disciplines.

Frontiers in Cell and Developmental Biology is a leading open-access journal published by FRONTIERS MEDIA SA, dedicated to advancing the understanding of fundamental biological processes at the cellular and developmental levels. Since its inception in 2013, the journal has positioned itself as a cornerstone of research in its field, achieving esteemed Q1 quartile rankings in both Cell Biology and Developmental Biology for 2023. With a robust Scopus ranking of #13 out of 82 in Developmental Biology and #67 out of 285 in Cell Biology, it represents a vital platform for innovative research and scholarly discourse. The journal provides a comprehensive and accessible avenue for researchers, professionals, and students alike to share high-quality findings and insights into cellular mechanisms and developmental processes, fostering collaboration and knowledge exchange in the global scientific community. Based in Lausanne, Switzerland, Frontiers in Cell and Developmental Biology is committed to open science, ensuring that all articles are freely accessible to the public, thereby broadening the impact of research in the biological sciences.

Established in 1887, the Journal of Morphology is a pioneering publication in the field of morphology, specializing in the anatomical and developmental biology of diverse organisms. Published by Wiley, this journal features high-quality research that spans multiple disciplines, including animal science and zoology, with a current ranking of Q2 in these areas. Although it lacks an open-access option, the journal is committed to advancing knowledge and facilitating scientific communication among professionals in developmental biology, as indicated by its ongoing contributions since its convergence years and up to 2024. With an impact factor that reflects its importance in the scientific community, the Journal of Morphology is a vital resource for researchers, professionals, and students seeking to understand complex morphological processes and their implications in modern science. Its dedication to publishing rigorous, peer-reviewed articles makes it an indispensable asset in the exploration of life's intricacies.

CURRENT PROTEIN & PEPTIDE SCIENCE, published by Bentham Science Publishers, is a pivotal journal dedicated to the dynamic and rapidly evolving fields of protein and peptide research. With an ISSN of 1389-2037 and an E-ISSN of 1875-5550, this esteemed journal serves as a platform for disseminating cutting-edge findings from various disciplines, including biochemistry, cell biology, and molecular biology. Recognized for its influence with a 2023 Scopus ranking placing it within the top quartiles of its categories—Q3 in Biochemistry, Q4 in Cell Biology, and Q2 in Medicine—the journal not only enhances the visibility of critical research but also supports the academic community in advancing our understanding of the molecular foundations of life. Established in 2000 and running through 2024, CURRENT PROTEIN & PEPTIDE SCIENCE is positioned to cater to the interests of researchers, professionals, and students alike, providing them with open access to vital knowledge that fuels innovation and scientific inquiry in the United Arab Emirates and beyond.

BIOLOGY OF THE CELL is a prominent academic journal published by Wiley, dedicated to advancing the field of cellular biology through the dissemination of innovative research and insights. With its ISSN (0248-4900) and E-ISSN (1768-322X), this journal has been a vital resource since its inception in 1981 and is set to continue its scholarly contributions until 2024. Positioned within the Q3 quartile in Cell Biology and Q2 in Medicine (miscellaneous) as of 2023, BIOLOGY OF THE CELL is recognized for its rigorous peer-review process and its commitment to high-quality publication in critical areas such as biochemistry, genetics, and molecular biology. Although the journal does not currently offer open access options, it remains accessible through the Wiley platform, ensuring that researchers, professionals, and students can benefit from its rich repository of knowledge. By linking fundamental cellular processes with broader medical implications, this journal serves as a critical platform for fostering dialogue and innovation in cellular research, making it an essential read for anyone engaged in the life sciences.

INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, published by Wiley, is a leading peer-reviewed journal dedicated to the field of experimental pathology. With an ISSN of 0959-9673 and E-ISSN 1365-2613, the journal has been a vital resource for researchers and professionals since its inception in 1990, covering a broad spectrum of topics within pathology, cell biology, and molecular biology. The journal's relevancy is underscored by its Q2 ranking in Pathology and Forensic Medicine and Q3 rankings in both Cell Biology and Molecular Biology, as of 2023, reflecting its significant contribution to the scientific community. Although it does not currently offer open access options, readers can benefit from its insightful research articles and reviews that guide advancements in diagnostic pathology and therapeutic strategies. As the journal continues to evolve, it remains committed to facilitating the exchange of innovative ideas and findings that drive progress in experimental pathology and related fields, making it an indispensable platform for scientists, clinicians, and students alike.

FEBS LETTERS, published by Wiley, is a prestigious journal that has firmly established its place in the fields of biochemistry, biophysics, genetics, molecular biology, cell biology, and structural biology. With an esteemed history dating back to 1968, this journal continues to be a vital resource for researchers and professionals involved in the biological sciences. It boasts impressive quartile rankings, including Q1 statuses in several categories such as Biochemistry and Genetics, reflecting its high impact factor and significant contribution to scientific discourse. FEBS LETTERS provides a platform for innovative findings and critical reviews, fostering the exchange of knowledge and ideas within the scientific community. Although it operates under a subscription model, the journal ensures broad dissemination of groundbreaking research through its rigorous peer-review process. The vibrant discussions encouraged by articles published in FEBS LETTERS aim to inspire current and future generations of scientists to push the boundaries of biological understanding, making it an indispensable resource for anyone dedicated to advancing their knowledge in these dynamic fields.

ACTA HISTOCHEMICA, a prestigious journal published by Elsevier GmbH, is dedicated to advancing the field of histochemistry and its applications within cell biology and medicine. With an ISSN of 0065-1281 and an E-ISSN of 1618-0372, the journal provides a critical platform for the dissemination of high-quality research findings and reviews, integral for both emerging and established scholars. Since its inception in 1954 and continuing through to 2024, ACTA HISTOCHEMICA has maintained a strong commitment to publishing significant advancements in histology and cell biology, as evidenced by its categorization in Q3 for Cell Biology and Histology, as well as Q2 in miscellaneous medicine for the year 2023. The journal ranks favorably in Scopus, holding the 27th rank in Histology and a 200th rank in Cell Biology, highlighting its importance to the academic community. With its headquarters in Munich, Germany, ACTA HISTOCHEMICA continues to attract contributions from global researchers, fostering an international dialogue essential for the growth of knowledge in histochemistry and related disciplines.

JOURNAL OF BIOLOGICAL CHEMISTRY, published by Elsevier, is a premier interdisciplinary journal dedicated to advancing our understanding of biochemistry, cell biology, and molecular biology. With a prestigious history dating back to 1945 and an impressive convergence of research expected to continue through 2024, this journal holds a Q1 ranking in all three of its core categories, signaling its critical influence in the respective fields, supported by a robust Scopus ranking that places it among the top echelons of internationally recognized research. Although currently not available as Open Access, the journal is essential for researchers and professionals looking to stay abreast of the latest breakthroughs and innovations in biochemical research. With a deep commitment to scientific rigor and a focus on diverse topics ranging from cellular processes to molecular mechanisms, the Journal of Biological Chemistry serves as a vital resource for the academic community, shaping the future of biological sciences.

CONNECTIVE TISSUE RESEARCH is a distinguished academic journal published by Taylor & Francis Inc, dedicated to the study of connective tissue within a broad spectrum of biomedical fields. Since its inception in 1972, this journal has emerged as a crucial platform for disseminating high-quality research findings, exploring fundamental and applied aspects of connective tissue biology. With its convergence stretching to 2024, CONNECTIVE TISSUE RESEARCH showcases innovative research in areas such as biochemistry, orthopedics, rheumatology, and cell biology, making significant contributions to our understanding of tissue structure and function. The journal holds a commendable impact factor and ranks notably in various categories, including a Q2 status in Biochemistry and Orthopedics, reflecting its pivotal role in advancing knowledge in these fields. Researchers and professionals can benefit from its offerings, which include original articles, reviews, and cutting-edge studies, all aimed at enhancing scientific inquiry and clinical applications. The journal remains committed to promoting accessibility through traditional subscription options, ensuring its wide reach in the academic community.